What is NDC 59212-200?

59212-200 is the product NDC for Uroxatral (alfuzosin hcl), Alfuzosin hydrochloride 10 mg/1 tablet, extended release, listed with the FDA by Advanz Pharma (US) Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Advanz Pharma (US) Corp., NDC labeler code 59212. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Uroxatral?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Uroxatral NDC 59212-200 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59212-200Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59212-0200Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59212-200-10	5921202001059212020010	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10)Marketed from Jun 3, 2013
59212-200-30	5921202003059212020030	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-30)Marketed from Jan 18, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Uroxatral
Generic name (nonproprietary): alfuzosin hcl
Active ingredients: Alfuzosin hydrochloride — 10 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Advanz Pharma (US) Corp.NDC labeler code 59212
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021287
Marketing start: Jun 3, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 59212-200_ffbc758d-7556-4269-8947-baa7ddb88541SPL ID ffbc758d-7556-4269-8947-baa7ddb88541SPL set ID 9fc7f119-f36b-44cf-945d-940160f3afe3RxCUI 861132, 861134UNII 75046A1XTN
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459212020010 followed by a unit qualifier and the quantity

Package 59212-0200-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2024.

Indications (excerpt from the label)

UROXATRAL is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. UROXATRAL is an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. ( 1 ) Important Limitations of Use: UROXATRAL is not indicated for treatment of hypertension. ( 1.1 ) UROXATRAL is not indicated for use in the pediatric population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use UROXATRAL is not indicated for the treatment of hypertension. UROXATRAL is not indicated for use in the pediatric population.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59212-200

What is NDC 59212-200?: 59212-200 is the product NDC for Uroxatral (alfuzosin hcl), Alfuzosin hydrochloride 10 mg/1 tablet, extended release, listed with the FDA by Advanz Pharma (US) Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Uroxatral (Alfuzosin HCl).
What is the active ingredient?: Alfuzosin hydrochloride.
Who is the labeler?: Advanz Pharma (US) Corp., NDC labeler code 59212. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Uroxatral?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Uroxatral (Alfuzosin hcl) NDC 59212-200